SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-030782
Filing Date
2021-12-08
Accepted
2021-12-08 08:05:17
Documents
14
Period of Report
2021-12-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38349
2 ex10-1.htm EX-10.1 19495
3 ex99-1.htm EX-99.1 18634
  Complete submission text file 0001493152-21-030782.txt   259262

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ocx-20211205.xsd EX-101.SCH 3022
5 XBRL LABEL FILE ocx-20211205_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ocx-20211205_pre.xml EX-101.PRE 22358
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3570
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 211477673
SIC: 2835 In Vitro & In Vivo Diagnostic Substances